Details for: HLA DMA

Gene ID: 3108

Gene Type:  Protein-coding  - A gene that serves as a template for producing a messenger RNA (mRNA) molecule, which is then translated into a functional protein.

Symbol: HLA DMA

Ensembl ID: ENSG00000204257

Description: major histocompatibility complex, class II, DM alpha

Selected Context(s):  Overall

Cell Significance Landscape

Contexts:

Associated with

Significant Cells

Cell Significance Index (CSI) scores for the chosen context(s)

  • plasmacytoid dendritic cell, human CL0001058
    CSI 75.19
    rCSI 52.5%
    PRS 90.06
  • naive B cell CL0000788
    CSI 58.03
    rCSI 49.77%
    PRS 90.84
  • class switched memory B cell CL0000972
    CSI 47.81
    rCSI 35.69%
    PRS 94.9
  • conventional dendritic cell CL0000990
    CSI 46.85
    rCSI 39.11%
    PRS 83.23
  • CD1c-positive myeloid dendritic cell CL0002399
    CSI 46.23
    rCSI 55.84%
    PRS 92.42
  • memory B cell CL0000787
    CSI 42.82
    rCSI 42.28%
    PRS 94.12
  • alternatively activated macrophage CL0000890
    CSI 42.06
    rCSI 52.88%
    PRS 93.24
  • myeloid dendritic cell CL0000782
    CSI 38.92
    rCSI 56.38%
    PRS 95.45
  • dendritic cell CL0000451
    CSI 38.36
    rCSI 47.27%
    PRS 87.46
  • small pre-B-II cell CL0000954
    CSI 37.36
    rCSI 35.92%
    PRS 95.18
  • alveolar macrophage CL0000583
    CSI 35.88
    rCSI 59.1%
    PRS 89.28
  • common dendritic progenitor CL0001029
    CSI 34.63
    rCSI 43.46%
    PRS 92.78
  • mature B cell CL0000785
    CSI 33.93
    rCSI 29.5%
    PRS 93.63
  • myeloid leukocyte CL0000766
    CSI 33.61
    rCSI 31.01%
    PRS 87.77
  • Langerhans cell CL0000453
    CSI 31.6
    rCSI 48.27%
    PRS 94.31
  • CD4-positive, CD25-positive, alpha-beta regulatory T cell CL0000792
    CSI 28.54
    rCSI 28.03%
    PRS 95.95
  • dendritic cell, human CL0001056
    CSI 28.18
    rCSI 43.27%
    PRS 93.02
  • CD14-positive, CD16-positive monocyte CL0002397
    CSI 28.05
    rCSI 36.75%
    PRS 94.19
  • mononuclear phagocyte CL0000113
    CSI 26.82
    rCSI 59.04%
    PRS 89.49
  • immature B cell CL0000816
    CSI 26.09
    rCSI 19.38%
    PRS 94.12
  • hematopoietic stem cell CL0000037
    CSI 25.78
    rCSI 17.14%
    PRS 88.57
  • plasmacytoid dendritic cell CL0000784
    CSI 24.94
    rCSI 25.26%
    PRS 93.78
  • unswitched memory B cell CL0000970
    CSI 24.68
    rCSI 20.76%
    PRS 95.73
  • CD4-positive, alpha-beta memory T cell CL0000897
    CSI 24.27
    rCSI 17.42%
    PRS 95.96
  • CD14-low, CD16-positive monocyte CL0002396
    CSI 22.65
    rCSI 17.45%
    PRS 89.77
  • erythrocyte CL0000232
    CSI 22.04
    rCSI 50.01%
    PRS 85.94
  • macrophage CL0000235
    CSI 21.61
    rCSI 39.31%
    PRS 89.11
  • transitional stage B cell CL0000818
    CSI 19.6
    rCSI 64.16%
    PRS 96.1
  • epithelial cell of lung CL0000082
    CSI 19.18
    rCSI 15.9%
    PRS 87.76
  • respiratory suprabasal cell CL4033048
    CSI 19.12
    rCSI 24.53%
    PRS 88.86
  • germinal center B cell CL0000844
    CSI 18.71
    rCSI 55.79%
    PRS 92.53
  • late pro-B cell CL0002048
    CSI 18.32
    rCSI 45.91%
    PRS 95.19
  • pro-B cell CL0000826
    CSI 16.83
    rCSI 13.93%
    PRS 88.59
  • B cell CL0000236
    CSI 16.16
    rCSI 21.62%
    PRS 89.7
  • mucous neck cell CL0000651
    CSI 16.1
    rCSI 23.21%
    PRS 90.8
  • lung macrophage CL1001603
    CSI 15.45
    rCSI 34.52%
    PRS 92.02
  • blood vessel endothelial cell CL0000071
    CSI 15.36
    rCSI 31.86%
    PRS 84.23
  • fallopian tube secretory epithelial cell CL4030006
    CSI 15.31
    rCSI 14.73%
    PRS 85.78
  • mature NK T cell CL0000814
    CSI 15.24
    rCSI 19.49%
    PRS 91.98
  • pancreatic acinar cell CL0002064
    CSI 15.19
    rCSI 20.2%
    PRS 90.71
  • effector memory CD8-positive, alpha-beta T cell CL0000913
    CSI 15.18
    rCSI 13.83%
    PRS 95.26
  • duct epithelial cell CL0000068
    CSI 14.99
    rCSI 21.94%
    PRS 90.6
  • colon macrophage CL0009038
    CSI 14.72
    rCSI 68%
    PRS 94.81
  • monocyte CL0000576
    CSI 14.51
    rCSI 26.22%
    PRS 88.97
  • central memory CD8-positive, alpha-beta T cell CL0000907
    CSI 14.39
    rCSI 9.69%
    PRS 95.96
  • follicular B cell CL0000843
    CSI 14.05
    rCSI 51.08%
    PRS 95.31
  • precursor B cell CL0000817
    CSI 13.95
    rCSI 12.22%
    PRS 91.66
  • M cell of gut CL0000682
    CSI 13.66
    rCSI 14.52%
    PRS 89.63
  • endothelial cell of artery CL1000413
    CSI 13.37
    rCSI 19.59%
    PRS 90.17
  • secretory cell CL0000151
    CSI 13.21
    rCSI 13.79%
    PRS 85.75
  • classical monocyte CL0000860
    CSI 12.95
    rCSI 19.19%
    PRS 93.66
  • CD14-positive monocyte CL0001054
    CSI 12.58
    rCSI 15.67%
    PRS 93.21
  • double negative thymocyte CL0002489
    CSI 12.19
    rCSI 8.47%
    PRS 95.34
  • non-classical monocyte CL0000875
    CSI 12.16
    rCSI 19.49%
    PRS 92.79
  • tracheal goblet cell CL1000329
    CSI 11.64
    rCSI 25.42%
    PRS 90.68
  • kidney interstitial alternatively activated macrophage CL1000695
    CSI 10.8
    rCSI 28.16%
    PRS 87.87
  • pulmonary capillary endothelial cell CL4028001
    CSI 10.79
    rCSI 20.58%
    PRS 93.52
  • lung interstitial macrophage CL4033043
    CSI 10.56
    rCSI 23.72%
    PRS 94.83
  • effector CD8-positive, alpha-beta T cell CL0001050
    CSI 10.48
    rCSI 7.97%
    PRS 95.95
  • ciliated cell CL0000064
    CSI 10.34
    rCSI 16.75%
    PRS 81.34
  • Kupffer cell CL0000091
    CSI 10.29
    rCSI 23.54%
    PRS 87.61
  • hematopoietic precursor cell CL0008001
    CSI 10.2
    rCSI 10.49%
    PRS 94.07
  • large pre-B-II cell CL0000957
    CSI 10.16
    rCSI 29%
    PRS 88.88
  • pancreatic ductal cell CL0002079
    CSI 9.94
    rCSI 19.33%
    PRS 89
  • myeloid dendritic cell, human CL0001057
    CSI 9.59
    rCSI 53.99%
    PRS 95.34
  • T follicular helper cell CL0002038
    CSI 8.85
    rCSI 6.62%
    PRS 95.46
  • enterocyte CL0000584
    CSI 8.61
    rCSI 13.88%
    PRS 84.33
  • IgA plasma cell CL0000987
    CSI 8.01
    rCSI 8.2%
    PRS 90.53
  • vein endothelial cell CL0002543
    CSI 7.99
    rCSI 21.81%
    PRS 90.91
  • plasmablast CL0000980
    CSI 7.93
    rCSI 6.24%
    PRS 90.06
  • ciliated epithelial cell CL0000067
    CSI 7.76
    rCSI 6.82%
    PRS 77.31
  • CD14-positive, CD16-negative classical monocyte CL0002057
    CSI 7.68
    rCSI 46.46%
    PRS 93.74
  • early lymphoid progenitor CL0000936
    CSI 7.56
    rCSI 6.64%
    PRS 90.4
  • effector CD4-positive, alpha-beta T cell CL0001044
    CSI 7.48
    rCSI 21.45%
    PRS 97.58
  • kidney connecting tubule epithelial cell CL1000768
    CSI 7.3
    rCSI 18.51%
    PRS 78.83
  • mature T cell CL0002419
    CSI 7.29
    rCSI 5.67%
    PRS 95.8
  • multi-ciliated epithelial cell CL0005012
    CSI 7.17
    rCSI 7.16%
    PRS 80.98
  • inflammatory macrophage CL0000863
    CSI 7.05
    rCSI 12.04%
    PRS 95.98
  • intermediate monocyte CL0002393
    CSI 7.03
    rCSI 10.61%
    PRS 91.12
  • fraction A pre-pro B cell CL0002045
    CSI 6.96
    rCSI 7.97%
    PRS 92.82
  • activated CD8-positive, alpha-beta T cell CL0000906
    CSI 6.95
    rCSI 6.83%
    PRS 95.48
  • glandular epithelial cell CL0000150
    CSI 6.68
    rCSI 17.6%
    PRS 94.33
  • hepatocyte CL0000182
    CSI 6.68
    rCSI 11.96%
    PRS 85.84
  • basal-myoepithelial cell of mammary gland CL0002324
    CSI 6.45
    rCSI 12.19%
    PRS 93.32
  • pulmonary ionocyte CL0017000
    CSI 6.42
    rCSI 7.81%
    PRS 91.4
  • group 3 innate lymphoid cell CL0001071
    CSI 6.21
    rCSI 4.67%
    PRS 90.94
  • promonocyte CL0000559
    CSI 6.09
    rCSI 10.43%
    PRS 90.16
  • myofibroblast cell CL0000186
    CSI 5.73
    rCSI 7.94%
    PRS 83.23
  • microglial cell CL0000129
    CSI 5.64
    rCSI 22.71%
    PRS 86.14
  • megakaryocyte-erythroid progenitor cell CL0000050
    CSI 5.24
    rCSI 4.73%
    PRS 85.33
  • IgM plasma cell CL0000986
    CSI 5.24
    rCSI 23.57%
    PRS 95.68
  • professional antigen presenting cell CL0000145
    CSI 5.17
    rCSI 17.8%
    PRS 92.38
  • pulmonary artery endothelial cell CL1001568
    CSI 5.03
    rCSI 6.84%
    PRS 92.29
  • CD8-positive, CD28-negative, alpha-beta regulatory T cell CL0000920
    CSI 5.01
    rCSI 9.99%
    PRS 94.71
  • chondrocyte CL0000138
    CSI 4.82
    rCSI 7.67%
    PRS 81.03
  • metallothionein-positive alveolar macrophage CL4033042
    CSI 4.79
    rCSI 52.08%
    PRS 92.9
  • IgG plasma cell CL0000985
    CSI 4.76
    rCSI 5.7%
    PRS 92.87
  • common myeloid progenitor CL0000049
    CSI 4.69
    rCSI 3.79%
    PRS 88.43
  • kidney loop of Henle thin ascending limb epithelial cell CL1001107
    CSI 4.56
    rCSI 11.79%
    PRS 83.1
  • CD8-positive, alpha-beta memory T cell, CD45RO-positive CL0001203
    CSI 4.38
    rCSI 5.31%
    PRS 67.05
  • erythroid progenitor cell CL0000038
    CSI 0.3
    rCSI 1.7%
    PRS 89.8%
  • cytotoxic T cell CL0000910
    CSI 0.5
    rCSI 3.1%
    PRS 87.5%
  • kidney resident macrophage CL1000698
    CSI 0.6
    rCSI 11.2%
    PRS 92.2%
  • lung microvascular endothelial cell CL2000016
    CSI 1.0
    rCSI 19.2%
    PRS 91.8%
  • prostate gland microvascular endothelial cell CL2000059
    CSI 1.0
    rCSI 23.9%
    PRS 91.7%
  • mammary gland epithelial cell CL0002327
    CSI 1.0
    rCSI 3.6%
    PRS 91.9%
  • collagen secreting cell CL0000667
    CSI 1.1
    rCSI 6.0%
    PRS 90.3%
  • basal cell of epithelium of trachea CL1000348
    CSI 1.2
    rCSI 8.1%
    PRS 88.9%
  • basal cell of epidermis CL0002187
    CSI 1.3
    rCSI 2.3%
    PRS 56.6%
  • deuterosomal cell CL4033044
    CSI 1.4
    rCSI 4.7%
    PRS 82.4%
  • tracheobronchial serous cell CL0019001
    CSI 1.5
    rCSI 6.3%
    PRS 90.6%
  • common lymphoid progenitor CL0000051
    CSI 1.6
    rCSI 2.1%
    PRS 96.4%
  • lymphoid lineage restricted progenitor cell CL0000838
    CSI 1.7
    rCSI 6.4%
    PRS 96.7%
  • memory T cell CL0000813
    CSI 1.8
    rCSI 3.4%
    PRS 97.1%
  • B-1 B cell CL0000819
    CSI 2.0
    rCSI 51.2%
    PRS 95.9%
  • effector memory CD8-positive, alpha-beta T cell, terminally differentiated CL0001062
    CSI 2.2
    rCSI 11.1%
    PRS 95.2%
  • foveolar cell of stomach CL0002179
    CSI 2.3
    rCSI 4.9%
    PRS 90.1%
  • kidney epithelial cell CL0002518
    CSI 2.3
    rCSI 4.5%
    PRS 95.2%
  • pre-conventional dendritic cell CL0002010
    CSI 2.3
    rCSI 30.9%
    PRS 96.4%
  • B-2 B cell CL0000822
    CSI 2.4
    rCSI 50.9%
    PRS 95.7%
  • respiratory goblet cell CL0002370
    CSI 2.7
    rCSI 29.1%
    PRS 91.2%
  • CD8-positive, alpha-beta cytotoxic T cell CL0000794
    CSI 2.7
    rCSI 3.2%
    PRS 96.5%
  • retinal blood vessel endothelial cell CL0002585
    CSI 3.0
    rCSI 4.9%
    PRS 89.7%
  • vein endothelial cell of respiratory system CL4033008
    CSI 3.0
    rCSI 20.9%
    PRS 90.8%
  • mature alpha-beta T cell CL0000791
    CSI 3.1
    rCSI 11.3%
    PRS 97.3%
  • vasa recta ascending limb cell CL1001131
    CSI 3.2
    rCSI 14.4%
    PRS 91.5%
  • granulocyte monocyte progenitor cell CL0000557
    CSI 3.2
    rCSI 2.8%
    PRS 89.6%
  • myeloid lineage restricted progenitor cell CL0000839
    CSI 3.5
    rCSI 17.9%
    PRS 96.2%
  • activated CD8-positive, alpha-beta T cell, human CL0001049
    CSI 3.6
    rCSI 6.2%
    PRS 94.8%
  • transit amplifying cell of colon CL0009011
    CSI 3.7
    rCSI 4.4%
    PRS 87.6%
  • hematopoietic multipotent progenitor cell CL0000837
    CSI 3.8
    rCSI 9.1%
    PRS 95.2%
  • promyelocyte CL0000836
    CSI 3.9
    rCSI 5.6%
    PRS 90.3%
  • choroid plexus epithelial cell CL0000706
    CSI 3.9
    rCSI 6.4%
    PRS 78.1%
  • megakaryocyte CL0000556
    CSI 3.9
    rCSI 17.0%
    PRS 89.5%
  • lung ciliated cell CL1000271
    CSI 4.0
    rCSI 4.6%
    PRS 80.4%
  • neutrophil CL0000775
    CSI 4.0
    rCSI 22.5%
    PRS 85.3%
  • colonocyte CL1000347
    CSI 4.1
    rCSI 5.9%
    PRS 85.9%
  • stratified epithelial cell CL0000079
    CSI 4.3
    rCSI 26.3%
    PRS 91.5%
  • vasa recta descending limb cell CL1001285
    CSI 4.4
    rCSI 34.9%
    PRS 92.1%
  • CD8-positive, alpha-beta memory T cell, CD45RO-positive CL0001203
    CSI 4.4
    rCSI 5.3%
    PRS 67.1%
  • kidney loop of Henle thin ascending limb epithelial cell CL1001107
    CSI 4.6
    rCSI 11.8%
    PRS 83.1%
  • common myeloid progenitor CL0000049
    CSI 4.7
    rCSI 3.8%
    PRS 88.4%
  • IgG plasma cell CL0000985
    CSI 4.8
    rCSI 5.7%
    PRS 92.9%
  • metallothionein-positive alveolar macrophage CL4033042
    CSI 4.8
    rCSI 52.1%
    PRS 92.9%
  • chondrocyte CL0000138
    CSI 4.8
    rCSI 7.7%
    PRS 81.0%
  • CD8-positive, CD28-negative, alpha-beta regulatory T cell CL0000920
    CSI 5.0
    rCSI 10.0%
    PRS 94.7%
  • pulmonary artery endothelial cell CL1001568
    CSI 5.0
    rCSI 6.8%
    PRS 92.3%
  • professional antigen presenting cell CL0000145
    CSI 5.2
    rCSI 17.8%
    PRS 92.4%
  • IgM plasma cell CL0000986
    CSI 5.2
    rCSI 23.6%
    PRS 95.7%
  • megakaryocyte-erythroid progenitor cell CL0000050
    CSI 5.2
    rCSI 4.7%
    PRS 85.3%
  • microglial cell CL0000129
    CSI 5.6
    rCSI 22.7%
    PRS 86.1%
  • myofibroblast cell CL0000186
    CSI 5.7
    rCSI 7.9%
    PRS 83.2%
  • promonocyte CL0000559
    CSI 6.1
    rCSI 10.4%
    PRS 90.2%
  • group 3 innate lymphoid cell CL0001071
    CSI 6.2
    rCSI 4.7%
    PRS 90.9%
  • pulmonary ionocyte CL0017000
    CSI 6.4
    rCSI 7.8%
    PRS 91.4%
  • basal-myoepithelial cell of mammary gland CL0002324
    CSI 6.5
    rCSI 12.2%
    PRS 93.3%
  • hepatocyte CL0000182
    CSI 6.7
    rCSI 12.0%
    PRS 85.8%
  • glandular epithelial cell CL0000150
    CSI 6.7
    rCSI 17.6%
    PRS 94.3%
  • activated CD8-positive, alpha-beta T cell CL0000906
    CSI 7.0
    rCSI 6.8%
    PRS 95.5%
  • fraction A pre-pro B cell CL0002045
    CSI 7.0
    rCSI 8.0%
    PRS 92.8%
  • intermediate monocyte CL0002393
    CSI 7.0
    rCSI 10.6%
    PRS 91.1%
  • inflammatory macrophage CL0000863
    CSI 7.1
    rCSI 12.0%
    PRS 96.0%
  • multi-ciliated epithelial cell CL0005012
    CSI 7.2
    rCSI 7.2%
    PRS 81.0%
  • mature T cell CL0002419
    CSI 7.3
    rCSI 5.7%
    PRS 95.8%
  • kidney connecting tubule epithelial cell CL1000768
    CSI 7.3
    rCSI 18.5%
    PRS 78.8%
  • effector CD4-positive, alpha-beta T cell CL0001044
    CSI 7.5
    rCSI 21.5%
    PRS 97.6%
  • early lymphoid progenitor CL0000936
    CSI 7.6
    rCSI 6.6%
    PRS 90.4%
  • CD14-positive, CD16-negative classical monocyte CL0002057
    CSI 7.7
    rCSI 46.5%
    PRS 93.7%
  • ciliated epithelial cell CL0000067
    CSI 7.8
    rCSI 6.8%
    PRS 77.3%
  • plasmablast CL0000980
    CSI 7.9
    rCSI 6.2%
    PRS 90.1%
  • vein endothelial cell CL0002543
    CSI 8.0
    rCSI 21.8%
    PRS 90.9%
  • IgA plasma cell CL0000987
    CSI 8.0
    rCSI 8.2%
    PRS 90.5%
  • enterocyte CL0000584
    CSI 8.6
    rCSI 13.9%
    PRS 84.3%
  • T follicular helper cell CL0002038
    CSI 8.9
    rCSI 6.6%
    PRS 95.5%
  • myeloid dendritic cell, human CL0001057
    CSI 9.6
    rCSI 54.0%
    PRS 95.3%
  • pancreatic ductal cell CL0002079
    CSI 9.9
    rCSI 19.3%
    PRS 89.0%
  • large pre-B-II cell CL0000957
    CSI 10.2
    rCSI 29.0%
    PRS 88.9%
  • hematopoietic precursor cell CL0008001
    CSI 10.2
    rCSI 10.5%
    PRS 94.1%
  • Kupffer cell CL0000091
    CSI 10.3
    rCSI 23.5%
    PRS 87.6%
  • ciliated cell CL0000064
    CSI 10.3
    rCSI 16.8%
    PRS 81.3%
  • effector CD8-positive, alpha-beta T cell CL0001050
    CSI 10.5
    rCSI 8.0%
    PRS 96.0%
  • lung interstitial macrophage CL4033043
    CSI 10.6
    rCSI 23.7%
    PRS 94.8%
  • pulmonary capillary endothelial cell CL4028001
    CSI 10.8
    rCSI 20.6%
    PRS 93.5%
  • kidney interstitial alternatively activated macrophage CL1000695
    CSI 10.8
    rCSI 28.2%
    PRS 87.9%
  • tracheal goblet cell CL1000329
    CSI 11.6
    rCSI 25.4%
    PRS 90.7%
  • non-classical monocyte CL0000875
    CSI 12.2
    rCSI 19.5%
    PRS 92.8%
  • double negative thymocyte CL0002489
    CSI 12.2
    rCSI 8.5%
    PRS 95.3%
  • CD14-positive monocyte CL0001054
    CSI 12.6
    rCSI 15.7%
    PRS 93.2%
  • classical monocyte CL0000860
    CSI 13.0
    rCSI 19.2%
    PRS 93.7%
  • secretory cell CL0000151
    CSI 13.2
    rCSI 13.8%
    PRS 85.8%
  • endothelial cell of artery CL1000413
    CSI 13.4
    rCSI 19.6%
    PRS 90.2%
  • M cell of gut CL0000682
    CSI 13.7
    rCSI 14.5%
    PRS 89.6%
  • precursor B cell CL0000817
    CSI 14.0
    rCSI 12.2%
    PRS 91.7%
  • follicular B cell CL0000843
    CSI 14.1
    rCSI 51.1%
    PRS 95.3%
  • central memory CD8-positive, alpha-beta T cell CL0000907
    CSI 14.4
    rCSI 9.7%
    PRS 96.0%
  • monocyte CL0000576
    CSI 14.5
    rCSI 26.2%
    PRS 89.0%
  • colon macrophage CL0009038
    CSI 14.7
    rCSI 68.0%
    PRS 94.8%
  • duct epithelial cell CL0000068
    CSI 15.0
    rCSI 21.9%
    PRS 90.6%
  • effector memory CD8-positive, alpha-beta T cell CL0000913
    CSI 15.2
    rCSI 13.8%
    PRS 95.3%
  • pancreatic acinar cell CL0002064
    CSI 15.2
    rCSI 20.2%
    PRS 90.7%

Cell ID: Standard Cell Ontology term used for mapping and comparing cells across experiments. Ensures consistency in analyzing cellular functions across tissues.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this specific cell.

Cell ID: Standard Cell Ontology term used for mapping and comparing cells across experiments. Ensures consistency in analyzing cellular functions across tissues.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this cell type. Calculated using techniques like effect size estimation and bootstrapping for reliability.

Cell ID: Standard Cell Ontology term used for mapping and comparing cells across experiments. Ensures consistency in analyzing cellular functions across tissues.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this cell type. Calculated using techniques like effect size estimation and bootstrapping for reliability.
Network Configuration

Explore relationships of the current gene. Select an Interaction Source: 'ONTOLOGY' for shared pathways (GO/Reactome) or 'STRING' for protein-protein interactions. Further refine by selecting context genes and comparing Cell Significance Index (CSI) scores between baseline and target cell types and their specific contexts.

Comma-separated if multiple.
Comma-separated if multiple.

Legend:
  • Query Gene
  • Node Color (Target Cell CSI, relative to current network):
    • Very High
    • High
    • Medium
    • Low
    • Very Low
    • CSI N/A
  • Node Size: Proportional to Target Cell CSI magnitude
  • STRING PPI Edge
  • Shared Pathway Edge (ONTOLOGY)

Loading network (please wait)...

Other Information

This section provides additional information about the gene, including a description generated by an AI language model and details about associated proteins.

## Summary [HLA DMA](/details-gene/3108), or Major Histocompatibility Complex, Class II, DM alpha, is a protein-coding gene located on chromosome 6. It plays a critical role in the adaptive immune system by facilitating the loading of antigenic peptides onto MHC class II molecules. This process is essential for the presentation of foreign antigens to T helper cells, thereby initiating a robust immune response. As a central component of this pathway, [HLA DMA](/details-gene/3108) shows highly specific and abundant expression in professional antigen-presenting cells (APCs), most notably in [plasmacytoid dendritic cell, human](/details-cell/CL0001058), various [B cell](/details-cell/CL0000236) subsets, and [macrophages](/details-cell/CL0000235). Dysregulation of its function is associated with immune-related disorders, as indicated by its clinical association with OMIM entry [142855](https://omim.org/entry/142855). ## Cellular Roles and Expression Landscape The expression profile of [HLA DMA](/details-gene/3108) underscores its specialized function within the professional antigen-presenting cell compartment of the immune system. **Overall**, the gene exhibits the highest significance in cells responsible for initiating adaptive immunity. The most significant expression is observed in: * [plasmacytoid dendritic cell, human](/details-cell/CL0001058) (CSI: 75.19) * [naive B cell](/details-cell/CL0000788) (CSI: 58.03) * [class switched memory B cell](/details-cell/CL0000972) (CSI: 47.81) * [conventional dendritic cell](/details-cell/CL0000990) (CSI: 46.85) * [alternatively activated macrophage](/details-cell/CL0000890) (CSI: 42.06) This strong and specific expression pattern across diverse subsets of dendritic cells (plasmacytoid, conventional, myeloid), the B cell lineage (naive, memory, mature), and macrophages highlights its fundamental role as a workhorse molecule in antigen processing and presentation. Its consistent high significance in these lineages suggests it is a core component of APC identity and function. ## Pathways and Molecular Function The molecular function of [HLA DMA](/details-gene/3108) is tightly linked to the [Mhc class ii antigen presentation](/details-pathway/R-HSA-2132295) pathway, a cornerstone of the [Adaptive immune system](/details-pathway/R-HSA-1280218). Functionally, it is a key player in [Antigen processing and presentation of exogenous peptide antigen via mhc class ii](/details-go/GO:0019886). The HLA-DMA protein forms a heterodimer with HLA-DMB and acts as a peptide editor or catalyst within endosomal/lysosomal compartments. Its primary role involves facilitating the release of the class II-associated invariant chain peptide (CLIP) from the newly synthesized MHC class II molecule. This action allows for the subsequent binding of higher-affinity antigenic peptides derived from extracellular pathogens. By ensuring that MHC class II molecules are loaded with a diverse and potent repertoire of foreign peptides ([Peptide antigen assembly with mhc class ii protein complex](/details-go/GO:0002503)), [HLA DMA](/details-gene/3108) is essential for the [Positive regulation of t cell activation](/details-go/GO:0050870) and the orchestration of the broader [Adaptive immune response](/details-go/GO:0002250). The activity of this complex is itself regulated, for instance through competitive inhibition by the HLA-DO complex, which can modulate the peptide repertoire presented to T cells [Link](https://doi.org/10.1038/nsmb.2460). ## Research Directions Given the central role of [HLA DMA](/details-gene/3108) in shaping the T cell repertoire, its dysregulation is a plausible driver of immune pathology. The following hypotheses could guide future research: 1. **Hypothesis 1: Role in Autoimmunity.** Allelic variants or altered expression of [HLA DMA](/details-gene/3108) in antigen-presenting cells may lead to inefficient CLIP removal or the preferential loading of self-peptides, breaking self-tolerance and contributing to the pathogenesis of autoimmune diseases such as type 1 diabetes or rheumatoid arthritis. 2. **Hypothesis 2: Impact on Vaccine Efficacy and Anti-Tumor Immunity.** The expression level of [HLA DMA](/details-gene/3108) in dendritic cells may be a critical determinant of vaccine efficacy and the strength of anti-tumor responses. Higher expression could enhance the presentation of vaccine- or tumor-derived antigens, leading to a more robust and diverse CD4+ T cell response. **Key Experimental Proposal:** To test the second hypothesis regarding the role of [HLA DMA](/details-gene/3108) in shaping immune responses, one could isolate monocytes from healthy donors and differentiate them into [dendritic cells](/details-cell/CL0000451). Using a CRISPR interference (CRISPRi) system, [HLA DMA](/details-gene/3108) expression would be knocked down. These knockdown cells, along with control cells, would then be pulsed with a known tumor neoantigen or a vaccine-specific antigen. Subsequently, the antigen-loaded dendritic cells would be co-cultured with autologous CD4+ T cells. The resulting T cell activation could be quantified by measuring proliferation (e.g., via CFSE dilution) and effector cytokine secretion (e.g., IFN-gamma by ELISA). A significantly diminished T cell response in the [HLA DMA](/details-gene/3108)-knockdown condition would validate the gene's critical role in generating effective T cell immunity. **Therapeutic Potential:** [HLA DMA](/details-gene/3108) represents a challenging but potentially valuable target for immunomodulation. As it functions intracellularly, it is not amenable to standard antibody-based therapies. However, its activity could be targeted with small molecules. For autoimmune disorders, a therapeutic strategy could involve the development of small molecule inhibitors that partially block HLA-DM's peptide editing function, thereby reducing the presentation of pathogenic autoantigens. Conversely, in the context of cancer immunotherapy or vaccine development, strategies to enhance the expression or functional activity of [HLA DMA](/details-gene/3108) within dendritic cell-based therapies could be explored to augment the presentation of tumor or pathogen-derived antigens, potentially leading to more potent and durable immune responses.

Genular Protein ID: 3786305756

Symbol: Q6ICR9_HUMAN

Name: N/A

UniProtKB Accession Codes:

Database IDs:

Citations:

PubMed ID: 23222639

Title: HLA-DO acts as a substrate mimic to inhibit HLA-DM by a competitive mechanism.

PubMed ID: 23222639

DOI: 10.1038/nsmb.2460

Sequence Information:

  • Length: 261
  • Mass: 29207
  • Checksum: BAAB2528874DFFC6
  • Sequence:
  • MGHEQNQGAA LLQMLPLLWL LPHSWAVPEA PTPMWPDDLQ NHTFLHTVYC QDGSPSVGLS 
    EAYDEDQLFF FDFSQNTRVP RLPEFADWAQ EQGDAPAILF DKEFCEWMIQ QIGPKLDGKI 
    PVSRGFPIAE VFTLKPLEFG KPNTLVCFVS NLFPPMLTVN WQHHSVPVEG FGPTFVSAVD 
    GLSFQAFSYL NFTPEPSDIF SCIVTHEIDR YTAIAYWVPR NALPSDLLEN VLCGVAFGLG 
    VLGIIVGIVL IIYFRKPCSG D